DETECT: Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients

Sponsor
Oculogica, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT02776462
Collaborator
(none)
321
2
24.6
160.5
6.5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the sensitivity and specificity of an aid in assessment of concussion based on eye-tracking, in comparison to a clinical reference standard appropriate for the Emergency Department (ED) or concussion clinic.

Study Design

Study Type:
Observational
Actual Enrollment :
321 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
Study Start Date :
Jun 1, 2016
Actual Primary Completion Date :
Nov 16, 2017
Actual Study Completion Date :
Jun 19, 2018

Arms and Interventions

Arm Intervention/Treatment
Potential Traumatic Brain Injury

This group will consist of people admitted to the ER, Trauma Bay, or Neurosurgery for potential traumatic brain injury.

Device: EyeBox CNS

Outcome Measures

Primary Outcome Measures

  1. A change in metrics of eye movement that enable positive concussion detection using BOX Score. [Immediately after eye tracking, within 2 weeks of injury]

    A True Positive rate for identifying Concussion as compared to a Clinical Reference standard.

Secondary Outcome Measures

  1. Change in Cognitive Function and Symptom Severity during Recovery as Measured with a Clinical Reference Standard for Concussion. [Immediately before eye tracking, between 1 week and 109 weeks post injury]

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 67 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Provide written informed consent.

  • Be between the ages of 4 and 67 years old.

  • Have a diagnosis of traumatic brain injury with a potential for concussion.

  • Subjects must have baseline vision correctable to within 20/500 bilaterally.

  • Subjects must have intact ocular motility.

  • Subjects must have ability to provide a complete ophthalmologic, medical and neurologic history as well as medications/drugs/alcohol consumed within the 24 hours prior.

Exclusion Criteria:
  • ER visit has been more than 2 weeks since the injury which may have caused the concussion.

  • Have received penetrating trauma or have a head CT demonstrating evidence of acute brain injury (subdural, epidural or intraparenchymal hemorrhage, edema/mass effect per attending radiologist read).

  • Suffering burns, anoxic injury or multiple/extensive injuries resulting in any medical, surgical or hemodynamic instability.

  • Blind (no light perception), are missing eyes, do not open eyes.

  • It is pertinent that subjects be able to detect light and have both eyes in order for the eye tracking data to be effective and significant.

  • Previous history of: ocular motility dysfunction or extensive prior eye surgery.

  • Any physical or mental injury or baseline disability rendering task completion difficult.

  • Obvious intoxication or blood alcohol level greater than 0.2.

Contacts and Locations

Locations

Site City State Country Postal Code
1 SkyRidge Medical Center Lone Tree Colorado United States 80124
2 Beaver Dam Community Hospital Beaver Dam Wisconsin United States 53916

Sponsors and Collaborators

  • Oculogica, Inc.

Investigators

  • Study Chair: Uzma Samadani, M.D., Ph.D., Hennepin County Medical Center, Minneapolis

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Oculogica, Inc.
ClinicalTrials.gov Identifier:
NCT02776462
Other Study ID Numbers:
  • DETECT TBI001
First Posted:
May 18, 2016
Last Update Posted:
Sep 7, 2018
Last Verified:
Sep 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Oculogica, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 7, 2018